Kite Pharma, Inc.: cash_and_equivalents

Value{"amount": 199601000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2016-03-31)
Statuscurrent
EntityKite Pharma, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-16-018576 · Open the official SEC filing →
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001510580/cash-and-equivalents/2016-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4ae70eb9-cc8b-4b61-b05e-1aef5ba77e48

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies